Literature DB >> 17671755

Molecular biology of hepatitis C virus.

Tetsuro Suzuki1, Hideki Aizaki, Kyoko Murakami, Ikuo Shoji, Takaji Wakita.   

Abstract

Infection with hepatitis C virus (HCV), which is distributed worldwide, often becomes persistent, causing chronic hepatitis, cirrhosis, and hepatocellular carcinoma. For many years, the characterization of the HCV genome and its products has been done by heterologous expression systems because of the lack of a productive cell culture system. The development of the HCV replicon system is a highlight of HCV research and has allowed examination of the viral RNA replication in cell culture. Recently, a robust system for production of recombinant infectious HCV has been established, and classical virological techniques are now able to be applied to HCV. This development of reverse genetics-based experimental tools in HCV research can bring a greater understanding of the viral life cycle and pathogenesis of HCV-induced diseases. This review summarizes the current knowledge of cell culture systems for HCV research and recent advances in the investigation of the molecular virology of HCV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671755     DOI: 10.1007/s00535-007-2030-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  185 in total

Review 1.  Escaping from the cell: assembly and budding of negative-strand RNA viruses.

Authors:  A P Schmitt; R A Lamb
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

2.  Ubiquitin as a central cellular regulator.

Authors:  Daniel Finley; Aaron Ciechanover; Alexander Varshavsky
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy.

Authors:  B Robertson; G Myers; C Howard; T Brettin; J Bukh; B Gaschen; T Gojobori; G Maertens; M Mizokami; O Nainan; S Netesov; K Nishioka; T Shin i; P Simmonds; D Smith; L Stuyver; A Weiner
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

4.  Characterization of three novel monoclonal antibodies against hepatitis C virus core protein.

Authors:  D Moradpour; T Wakita; K Tokushige; R I Carlson; K Krawczynski; J R Wands
Journal:  J Med Virol       Date:  1996-03       Impact factor: 2.327

5.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

Authors:  E A Brown; H Zhang; L H Ping; S M Lemon
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

7.  Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.

Authors:  P J Bredenbeek; I Frolov; C M Rice; S Schlesinger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  ORF1a-encoded replicase subunits are involved in the membrane association of the arterivirus replication complex.

Authors:  Y van der Meer; H van Tol; J K Locker; E J Snijder
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2.

Authors:  Stephanie T Shi; Ki-Jeong Lee; Hideki Aizaki; Soon B Hwang; Michael M C Lai
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Homotypic interaction and multimerization of hepatitis C virus core protein.

Authors:  M Matsumoto; S B Hwang; K S Jeng; N Zhu; M M Lai
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

View more
  41 in total

1.  Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing.

Authors:  Michael Lauck; Mónica V Alvarado-Mora; Ericka A Becker; Dipankar Bhattacharya; Rob Striker; Austin L Hughes; Flair J Carrilho; David H O'Connor; João R Rebello Pinho
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  N 6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling.

Authors:  Geon-Woo Kim; Hasan Imam; Mohsin Khan; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2020-07-27       Impact factor: 5.157

Review 3.  MicroRNAs and liver disease.

Authors:  Thomas A Kerr; Kevin M Korenblat; Nicholas O Davidson
Journal:  Transl Res       Date:  2011-02-02       Impact factor: 7.012

4.  Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease.

Authors:  Ye Yu; Jing-feng Jing; Xian-kun Tong; Pei-lan He; Yuan-chao Li; You-hong Hu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2014-07-21       Impact factor: 6.150

5.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

6.  Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.

Authors:  Robert Smolic; Martina Smolic; John H Andorfer; Catherine H Wu; Robert M Smith; George Y Wu
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

7.  Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.

Authors:  Hana Cho; Hyung Chul Lee; Sung Key Jang; Yoon Ki Kim
Journal:  Virus Genes       Date:  2008-06-20       Impact factor: 2.332

8.  Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions.

Authors:  Li-Shuang Ai; Yu-Wen Lee; Steve S-L Chen
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.

Authors:  Ahmed A Al-Qahtani; George Kessie; Damian Dela Cruz; Faleh Z Al-Faleh; Mohammed N Al-Ahdal
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

10.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.